Adverse Cardiovascular Effects of Anticholinesterase Medications
- 1 January 1987
- journal article
- case report
- Published by Elsevier in The American Journal of the Medical Sciences
- Vol. 293 (1), 18-23
- https://doi.org/10.1097/00000441-198701000-00005
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Psychologic Stress, Vasodepressor (Vasovagal) Syncope, and Sudden DeathAnnals of Internal Medicine, 1978
- Cardiac Arrhythmias Resulting from Tracheal SuctioningAnnals of Internal Medicine, 1969
- Distribution of cholinesterase within the sinus node and AV node of the human heartThe Anatomical Record, 1966
- TREATMENT OF MYASTHENIA GRAVIS WITH MESTINON BROMIDEJAMA, 1956
- WIN 8077 in the treatment of sixty myasthenia gravis patientsThe American Journal of Medicine, 1955
- Pharmacology of the anticholinesterase drugs—mestinon, prostigmin, tensilon and TEPPThe American Journal of Medicine, 1955
- Abnormalities in neuromuscular transmission, with special reference to myasthenia gravisThe American Journal of Medicine, 1953
- RAPID DIAGNOSTIC TEST FOR MYASTHENIA GRAVISJAMA, 1952
- Prostigmin in the Diagnosis of Myasthenia GravisNew England Journal of Medicine, 1935
- TREATMENT OF MYASTHENIA GRAVIS WITH PHYSOSTIGMINEThe Lancet, 1934